|
|
||||||||
Biology of Reproduction, Vol 21, 1143-1152, Copyright © 1979 by Society for the Study of Reproduction
1 Reproductive Physiology,
Oregon Regional Primate Research Center,
Beaverton, Oregon 97006 Glycogen, a leukocyte chemotactic agent, was used to induce transient leukocytosis in rat uteri
during pregnancy. Large numbers of polymorphonuclear leukocytes (PMNLs) were attracted to the
uterine endometrium and lumen after a single intrauterine injection of soluble glycogen (ligated
horns) or glycogen-releasing gelatin beads (nonligated horns). Glycogen treatment on Days 3
through 5 of pregnancy (Day 5 = implantation) caused complete termination of pregnancy and
significantly reduced fertility on Days 2 and 6 of pregnancy. However, fertility was unaffected by
glycogen treatment after Day 6 of pregnancy even though a substantial leukocytic response was
also elicited by glycogen in rats during later stages of gestation. This study indicates that glycogeninduced uterine leukocytosis effectively terminates pregnancy before and during the implantation
stage. We propose that leukocyte chemotactic agents such as glycogen may prove clinically useful
as abortifacient agents or may be used to improve the contraceptive efficiency of intrauterine
devces.
Note:
ACKNOWLEDGMENTS
The research reported in this article, Publication
No. 1058 of the Oregon Regional Primate Research
Center, was supported by the Program for Applied
Research on Fertility Regulation, Northwestern
University, under contract AID/csd-3608. The authors
wish to thank Mary Boudreaux and Belinda Toyooka
for excellent technical assistance and Patsy Kimzey for
helping with the preparation of this manuscript.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |